Models | Covariates | ACR (n = 141) | |||
---|---|---|---|---|---|
Normal (n = 106) | Nephropathy (n = 35) | ||||
OR (95 % CI) | P | OR (95 % CI) | P | ||
Model 1 | Betatrophin | 1.00 | – | 5.63 (2.17–14.57) | <0.001* |
DM duration | 1.00 | – | 1.08 (1.00–1.15) | 0.040* | |
hsCRP | 1.00 | – | 1.91 (0.91–3.98) | 0.086 | |
SBP | 1.00 | – | 1.03 (0.99–1.06) | 0.103 | |
HbA1c | 1.00 | – | 1.11 (0.86–1.44) | 0.434 | |
TG | 1.00 | – | 1.00 (0.99–1.01) | 0.092 | |
Model 2 | Betatrophin | 1.00 | – | 6.36 (2.78–14.55) | <0.001* |
DM duration | 1.00 | – | 1.09 (1.03–1.16) | 0.002* | |
hsCRP | 1.00 | – | 2.90 (1.17–7.20) | 0.022* | |
SBP | 1.00 | – | 1.03 (1.01–1.06) | 0.012* | |
HbA1c | 1.00 | – | 1.27 (1.03–1.56) | 0.026* | |
TG | 1.00 | – | 1.01 (1.00–1.01) | 0.005* | |
Model 3 | Betatrophin | 1.00 | – | 5.79 (2.51–13.32) | <0.001* |
DM duration | 1.00 | – | 1.10 (1.05–1.17) | <0.001* | |
hsCRP | 1.00 | – | 3.19 (1.28–7.97) | 0.013* | |
SBP | 1.00 | – | 1.04 (1.01–1.06) | 0.004* | |
HbA1c | 1.00 | – | 1.33 (1.08–1.64) | 0.007* | |
TG | 1.00 | – | 1.01 (1.00–1.01) | 0.006* | |
Model 4 | Betatrophin | 1.00 | – | 5.43 (2.44–12.09) | <0.001* |
DM duration | 1.00 | – | 1.10 (1.04–1.16) | 0.001* | |
hsCRP | 1.00 | – | 2.44 (1.10–5.43) | 0.029* | |
SBP | 1.00 | – | 1.03 (1.01–1.06) | 0.010* | |
HbA1c | 1.00 | – | 1.28 (1.04–1.56) | 0.018* | |
TG | 1.00 | – | 1.00 (1.00–1.01) | 0.014* | |
Model 5 | Betatrophin | 1.00 | – | 5.65 (2.39–13.33) | <0.001* |
DM duration | 1.00 | – | 1.10 (1.03–1.16) | 0.002* | |
hsCRP | 1.00 | – | 2.73 (1.11–6.72) | 0.029* | |
SBP | 1.00 | – | 1.03 (1.00–1.06) | 0.021* | |
HbA1c | 1.00 | – | 1.26 (1.01–1.56) | 0.036* | |
TG | 1.00 | – | 1.01 (1.00–1.01) | 0.017* |